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HIGHLIGHTS 14 
 15 
The functional effects of known ototoxins were studied in the zebrafish lateral line. 16 
 17 
Ototoxins cause cellular damage to hair cells present in lateral line neuromasts. 18 
 19 
Consequences of the damage are attenuated startle, rheotactic and avoidance reflexes. 20 
 21 
The zebrafish ear may contribute to initiating the noise-evoked startle reflex. 22 
 23 
When combined, zebrafish assays are sensitive pre-clinical detectors of ototoxicity.24 
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ABSTRACT 25 
The ototoxicity of a number of marketed drugs is well documented, and there is an 26 
absence of convenient techniques to identify and eliminate this unwanted effect at a pre-27 
clinical stage. We have assessed the validity of the larval zebrafish, or more specifically 28 
its lateral line neuromast hair cells, as a microplate-scale in vivo surrogate model of 29 
mammalian inner ear hair cell responses to ototoxin exposure. Here we describe an 30 
investigation of the pathological and functional consequences of hair cell loss in lateral 31 
line neuromasts of larval zebrafish after exposure to a range of well known human and 32 
non-human mammalian ototoxins. Using a previously described histological assay, we 33 
show that hair cell damage occurs in a concentration-dependent fashion following 34 
exposure to representatives from a range of drug classes, including the aminoglycoside 35 
antibiotics, salicylates and platinum-based chemotherapeutics, as well as a heavy metal. 36 
Furthermore, we detail the optimisation of a semi-automated method to analyse the 37 
stereotypical startle response in larval zebrafish, and use this to assess the impact of 38 
hair cell damage on hearing function in these animals.  Functional assessment revealed 39 
robust and significant attenuation of the innate startle, rheotactic and avoidance 40 
responses of 5 day old zebrafish larvae after treatment with a number of compounds 41 
previously shown to induce hair cell damage and loss. Interestingly, a startle reflex 42 
(albeit reduced) was still present even after the apparent complete loss of lateral line hair 43 
cell fluorescence, suggesting some involvement of the inner ear as well as the lateral 44 
line neuromast hair cells in this reflex response. Collectively, these data provide 45 
evidence to support the use of the zebrafish as a pre-clinical indicator of drug-induced 46 
histological and functional ototoxicity.  47 
 48 
 49 
 50 
 51 
 52 
 53 
Key words: zebrafish, ototoxicity, hair cell, startle reflex, hearing function, neuromast, 54 
rheotaxis, avoidance behaviour 55 
56 
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1. INTRODUCTION* 56 
Ototoxins are compounds known to cause damage to the hearing and balance systems 57 
of animals.  The existence of ototoxins has been documented since the 1800s, most 58 
notably with the emergence of new medicines such as the antimalarials in 1843, 59 
aminoglycoside antibiotics in the 1940s and the cytotoxic chemotherapeutics in the 60 
1970s (Schacht and Hawkins, 2006). In more recent times, it has been reported that 61 
over 130 common medicines are ototoxic (Seligmann et al., 1996). It is currently 62 
estimated that 9 million people in the UK suffer from hearing impairment, with many 63 
more suffering from vestibular damage and tinnitus (AHL, 2011). In a proportion of these 64 
individuals, hearing and vestibular damage will have been induced by common ototoxic 65 
medications such as aminoglycosides, antimalarials, salicylates, loop diuretics and 66 
antineoplastic agents (Rybak, 1986). Despite this, there is currently no standard pre-67 
clinical assay for drug-induced ototoxicity. 68 
 69 
In recent years, studies have begun to explore the value of the zebrafish as a model for 70 
assessing ototoxicity. Zebrafish are so-called “hearing specialists”, using a combination 71 
of their acoustico-lateralis system, swim bladder and Weberian ossicles to detect sound 72 
(Fay and Popper, 1974). The acoustico-lateralis system consists of an inner ear 73 
(containing semicircular canals and the utricular, saccular and lagenar maculae) and a 74 
lateral line system composed of mechanosensory neuromast organs (Bever and Fekete, 75 
2002; Ghysen and Dambly-Chaudière, 2004; Metcalfe et al., 1985; Metcalfe, 1989; 76 
Raible and Kruse, 2000; Whitfield et al., 2002). The function of the lateral line (LL) is to 77 
detect local water flow and low frequency vibration, mediating behaviours such as 78 
schooling and predator avoidance (Dijkgraaf, 1963; Ghysen and Dambly-Chaudière, 79 
2004; Kaus, 1987). From 5 days post fertilisation (dpf) until adulthood, there are no 80 
significant alterations in the sensitivity of the lateral line to vibratory stimuli, making 5dpf 81 
an ideal age for both histological and functional studies (Zeddies and Fay, 2005). 82 
 83 
                                                
* Abbreviations: AER, auditory evoked response; ALD, average large distance; dpf, days post 
fertilisation; DWC, dilution water control; GFP, green fluorescent protein; ISI, inter-stimulus 
interval; LL, lateral line; LLC, long-latency C-start; MTC, maximum tolerated concentration; pLL, 
posterior lateral line; SC, solvent control; SLC, short-latency C-start; SPL, sound pressure level; 
SR, seeker response; Vpp, voltage peak to peak.  
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The emphasis of previous studies of ototoxicity in larval zebrafish has been on the 84 
histological damage caused to the neuromast hair cells (Chiu et al., 2008; Coffin et al., 85 
2009; Harris et al., 2003; Ou et al., 2007; Owens et al., 2007). More recent work has 86 
focused on identifying genetic and chemical modulators of ototoxic damage and the 87 
regeneration of LL hair cells (Brignull et al., 2009; Coffin et al., 2010; Ou et al., 2009; Ou 88 
et al., 2010; Owens et al., 2008; Owens et al., 2009; Ton and Parng, 2005). In addition 89 
to ototoxicity studies, the zebrafish has also been shown to be a useful model of human 90 
congenital hearing loss (Whitfield, 2002), as well as demonstrating similar vestibular 91 
functional circuits to humans (Mo et al., 2010).  92 
 93 
In terms of quantifiable functionality, the acoustically-evoked startle reflex, or C-start, is 94 
in place by 5 dpf, at around the same time the hair cells of the lateral line are proposed 95 
to be mature and mechanotransductively active (Kimmel et al., 1974; Murakami et al., 96 
2003; Santos et al., 2006). This escape reflex, proposed to be mediated by the lateral 97 
line, is instrumental in predator evasion and can also be evoked by touch and visual 98 
cues (McHenry et al., 2009). High speed auditory-evoked responses (AERs) are 99 
characterised by an initial whole body flexion (with an estimated angle of 90-220º 100 
occurring in the first 6-14 milliseconds after stimulation), followed by a strong counter-101 
bend and subsequent smaller flexions. The response lasts approximately 40ms and is 102 
initiated by Mauthner, MiD2cm and MiD3cm reticulospinal neurons (Kimmel et al., 1980; 103 
Liu and Fetcho, 1999). The C-start can be described as short or long latency (SLC and 104 
LLC respectively), with the SLC being the stronger response (Burgess and Granato, 105 
2007). Similarly, the ability of larvae to orientate to, and swim against, currents is termed 106 
rheotaxis (Arnold, 1974), and rheotactic behaviours can clearly be observed in free-107 
swimming larvae at 5 dpf. Again, rheotaxis has been shown to be mediated in part by 108 
the lateral line (Johnson et al., 2007; Montgomery et al., 1997). 109 
 110 
This study aimed to investigate the pathological and, perhaps more importantly, the 111 
functional consequences of exposure to a range of known human and non-human 112 
mammalian ototoxins in the zebrafish lateral line. This was achieved by quantifying the 113 
amount of hair cell damage using a previously described vital dye-based fluorescence 114 
assay, and by measuring the ability of animals to respond to auditory and other 115 
mechanosensory cues via stereotypical AER, rheotactic and avoidance behaviours. To 116 
our knowledge, this is the first study to use integrated auditory-evoked startle, rheotaxis 117 
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and seeker response assays to demonstrate the functional consequences of hair cell 118 
damage in the larval zebrafish following exposure to a range of ototoxins. Our data 119 
support the use of the zebrafish larva as a potentially valuable surrogate model for 120 
assessing drug-induced damage to mammalian inner ear hair cells.   121 
 122 
2. METHODS 123 
2.1 Animal husbandry 124 
Wild-type zebrafish (AB strain, Sheffield brood stock, UK) adults were used both at 125 
Sheffield and Brixham Environmental Laboratory. Tg(pou4f3::mGFP) adult zebrafish 126 
(Xiao et al., 2005) were used at Sheffield only. Adult fish were maintained on a 14 hour 127 
light/10 hour dark cycle according to standard protocols (Nüsslein-Volhard and Dahm, 128 
2002) and induced to breed using group spawning tanks. Egg collection and staging was 129 
performed according to standard procedures (Kimmel et al., 1995; Nüsslein-Volhard and 130 
Dahm, 2002). Larvae were raised at a density of 50 (or 128 in the case of the raising 131 
density experiments) per 90 mm Petri dish (Sterilin, Newport, UK), at 28°C (± 0.5°C) in 132 
standard E3 culture medium (5mM NaCl, 0.17mM KCl, 0.33 mM CaCl2, 0.33 mM 133 
MgSO4, 0.0001% methylene blue). For vital dye staining, fish were transferred into E3 134 
culture medium without methylene blue at 2 dpf to prevent methylene blue uptake into 135 
cells.  136 
 137 
All compound exposures, hair cell assessments, and functional testing were carried out 138 
on larvae aged 5 dpf. 139 
 140 
2.2 Compound selection and treatments 141 
All positive compounds were selected based on reported ototoxic effects in humans and 142 
non-human mammals (Brunton et al., 2006; Chiu et al., 2008; Joint Formulary 143 
Committee, 2011; Linbo et al., 2006; Prestayko et al., 1979; Rybak, 1986), with the 144 
exception of copper sulphate, which was chosen for its known ototoxicity in fish 145 
(Hernández et al., 2006; Olivari et al., 2008).  146 
 147 
Negative control compounds were selected that exhibited no reported ototoxicity in any 148 
species, and had no additional reported behavioural, locomotor or visual effects (Brunton 149 
et al., 2006; Colucci et al., 2002; Crino et al., 1999b; Crino et al., 1999a; Joint Formulary 150 
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Committee, 2011; Palumbo et al., 2010; Pinguet et al., 2000; Reller et al., 1973; Ribner 151 
et al., 1983; Salvo et al., 2007; Sandler and Ettinger, 1999; Von der Maase et al., 1999).  152 
 153 
All compounds and reagents were obtained from Sigma-Aldrich (UK), unless otherwise 154 
stated (for test compound details, see Suppl. Table S1). Acute compound exposures 155 
were performed in 24-well plates (Corning Costar, NY, USA) by immersion of 5 dpf 156 
larvae in E3 alone (also referred to as dilution water control (DWC)), or E3 containing 0-157 
2% DMSO or methanol as a solvent control (SC). The Maximum Tolerated 158 
Concentration (MTC) of each compound was determined by initial exposures (minimum 159 
of 6 larvae per concentration for each trial) and was classed as the concentration of 160 
compound that induced ≥20% mortality after a timed exposure (Suppl. Table S1).  161 
 162 
Using the MTC data, appropriate concentration ranges and exposure times were defined 163 
for the definitive compound exposures and subsequent hair cell damage and functional 164 
assessments. Treatment times and concentrations were specific to each compound 165 
tested (Suppl. Table S1). After compound exposure, larvae were rinsed 3 times with E3 166 
and left to recover for a further 60 minutes prior to further processing. For each 167 
exposure, an appropriate DWC/SC was used alongside a positive control, which was 168 
neomycin (100 or 300 µM dependent upon assay type). 169 
 170 
2.3 Neuromast hair cell staining and scoring 171 
The fluorescent vital dyes DASPEI (2-[4-(dimethylamino)styryl]-N-ethylpyridinium iodide 172 
(CAS No. 3785-01-1)) and FM1-43FX (Invitrogen; F-35355) were used to mark hair cells 173 
within the lateral line neuromasts. After compound exposure and recovery, larvae were 174 
incubated in E3 containing either DASPEI (0.05 mg/mL) for 20 minutes, or FM1-43FX (3 175 
µM) for 45 seconds. All labelling was carried out under dark conditions. Following 176 
DASPEI and FM1-43FX exposure, larvae were rinsed 3 times with E3. For both scoring 177 
and imaging, larvae were anaesthetised in MS222 (0.5 mM 3-aminobenzoic acid ethyl 178 
ester). Larvae were scored for fluorescence based on DASPEI labelling alone. For 179 
scoring, larvae were observed under an epifluorescence dissecting microscope (Leica 180 
MZ-12 FLIII) equipped with a GFP1 filter set (excitation 425/60 nm; barrier filter 480 nm). 181 
Nine individual neuromasts of the posterior lateral line (pLL) that were present at 5 dpf 182 
were scored for fluorescence (Fig. 2Ji). The scoring scheme used was based on 183 
previous work (Harris et al., 2003) and was as follows: strong staining indicating the 184 
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presence of hair cells, score = 2; weak reduced staining indicating the presence of fewer 185 
or damaged hair cells, score = 1; an absence of staining indicating the absence or 186 
severe damage of hair cells, score = 0.  See Fig. 2Jii, Jiii for examples of neuromasts 187 
exhibiting strong and weak staining. Each fish was scored on both sides, giving a 188 
maximum total score of 36 per larva. A minimum of 8 larvae per treatment group per trial 189 
was scored and an average taken from 3 to 4 trials (except in the case of gemcitabine, 190 
where 5 larvae per treatment group were assessed over a single trial). The concentration 191 
relating to approximately a 50% reduction in score (IC50) was ascertained for each 192 
compound using either log(concentration of test compound) versus response (three 193 
parameters) or log(concentration of test compound) versus response-variable slope (four 194 
parameters) curve-fitting equations (Prism 5.0 (GraphPad Software Inc., USA)). The best 195 
fit values (Fig. 3J) were used later as the IC50 for the startle assay. Six positive and three 196 
negative compounds were selected for use in further behavioural assays to study the 197 
functional consequences of ototoxin exposure. 198 
 199 
2.4 Startle assay 200 
2.4.1 Experimental apparatus 201 
A schematic of the experimental setup used to assess lateral line functionality is shown 202 
in Fig. 1. Vibratory stimuli (sinusoidal/square tone bursts) were generated using a 2.0 203 
MHz PCGU1000 PC function generator and controlled using PClab2000SE generator 204 
interface software (Velleman Inc., USA). Stimuli were amplified (SP103 amplifier; 205 
Acoustic Solutions, UK) and directed through a vertically oriented 15” (381 mm) speaker 206 
cone, housed in a wooden casing. Acoustic stimuli were delivered to the larvae through 207 
a 6.4 mm thick translucent plastic base plate, bolted to the speaker case, to which the 208 
microplate containing the larvae was fixed. Larvae under investigation were placed into 209 
24-well plates with a single larva per well. In all cases, the external surfaces of the plates 210 
were frosted using acetone. This served to provide a uniform opaque background 211 
against which to observe animal movement, and also to prevent larvae from receiving 212 
visual startle cues from animals in neighbouring wells. The 24-well plate was securely 213 
bolted to the base plate. Wave output parameters were measured using a calibrated 35 214 
MHz 4-channel digital storage oscilloscope (PM3305 (U), Phillips, Netherlands). Larval 215 
startle responses (auditory-evoked high-speed movements) were captured using a high-216 
speed 0.3 megapixel digital video camera (GRAS-03K2M, Point Grey Research Inc., 217 
Canada) set at a 60 frames/second capture rate. Recordings were visualised and 218 
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processed using VideoTrack for Zebrafish™ software (Viewpoint Inc., France). The 219 
Viewpoint software automated the allocation of each component of the movement of the 220 
larvae into bins based on thresholds that were previously set following visual observation 221 
of the speed of startle in 5 dpf larvae. The tracking software threshold was set at 21.1 222 
mm s-1, which was the level required to discriminate between stereotypical startle and 223 
normal movement. This threshold was determined by comparing multiple video 224 
recordings on a score by eye versus automation basis (data not shown). 225 
 226 
[Figure 1 to go near here] 227 
 228 
2.4.2 Stimulus form  229 
Stimuli consisted of sinusoidal or square waves of either 440 or 540 ms duration. The 230 
stimulus frequencies used were 40, 50, 100, 150, 200, 300, 400, and 500 Hz. For each 231 
frequency, conditions were optimised for voltage peak to peak (Vpp) and amplifier 232 
volume (-dBTP) to ensure purity (non-distortion) of the resultant sound wave (Suppl. 233 
Table S2). 234 
 235 
2.4.3 Sound pressure level measurement and calibration 236 
The 17 mm diameter wells of a 24-well plate were too small for direct measurement of 237 
the sound pressure level (SPL) using a standard hydrophone. Therefore, to measure the 238 
SPL inside the wells of the microplate indirectly, a small microphone (TCM110 omni-239 
directional electret-condenser, RS Components Ltd., UK), waterproofed with a latex 240 
sheath, was calibrated against a pre-calibrated SPL meter (Castle GA213; Castle Group 241 
Ltd., UK) in air, and subsequently in wells filled with 2 mL of E3. Measurements were 242 
taken over all test frequencies at previously optimised voltage settings (1.6–4.5 Vpp) for 243 
a small range of amplifier volumes (-40 to -10 dBTP). The output of the microphone was 244 
routed through the calibrated oscilloscope providing a direct measure between the SPL 245 
meter and the microphone, and consequently the attenuation in air versus that in fluid. 246 
The SPL meter was clamped at 35 mm above one of the four central wells (well 4C). In 247 
addition, the microphone wire was adhered directly to the SPL meter, to ensure that it 248 
was vertically positioned and adjacent to the meter. The microphone recordings in either 249 
air or water were then taken inside the centre of the well adjacent to well 4C, 5 mm 250 
above the bottom of the well. 251 
 252 
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2.4.4 Determination of threshold responses of larvae 253 
Threshold responses of larvae were determined for each frequency to ensure that 254 
maximum larval responses occurred at the lowest possible volume. A sub-threshold 255 
stimulus was given, which represented the lowest audible volume, and this was followed 256 
by 5 equally spaced sequential stimuli, up to a maximum volume threshold (the 257 
maximum volume attainable before distortion of waveform). Stimulus volume was 258 
chosen based on the best response at the lowest volume for each frequency. The 259 
responses of 24 larvae were tested over 3 repeated stimuli for each individual frequency. 260 
 261 
2.4.5 Plate type 262 
To test whether the capacity of the assay could be increased by using more wells per 263 
experiment, larval AERs were tested in either 24- or 48-well plates. For each individual 264 
test, larvae were equilibrated on the startle platform for a minimum of 30 minutes. 265 
Animals were then presented with eight selected frequencies (40, 50, 100, 150, 200, 266 
300, 400 and 500 Hz) at previously optimised voltages and volumes, with a duration of 267 
440 ms or 540 ms. The ISI was 60-80 seconds. For both conditions (24- and 48-well 268 
plates), tests were carried out in triplicate with a total of either 24 or 48 larvae per trial. 269 
All subsequent experiments described used the 24-well plate format. 270 
 271 
2.4.6 Wave type 272 
Twenty-four larvae (5 dpf) were individually loaded into each well of a microplate and 273 
allowed to equilibrate for 30 minutes. Three stimuli (200Hz, 440 ms duration) of either a 274 
square or sinusoidal waveform were presented with a minimum inter-stimulus interval 275 
(ISI) of 60 seconds. The averaged AERs of the larvae for each wave type were then 276 
compared.  277 
 278 
2.4.7 Density of raising 279 
To assess the effect of the density of culture on animal startle responses, larvae were 280 
raised to 5 dpf at a density of 50 or 128 per Petri dish. Larvae were individually loaded 281 
into microplates, and left to equilibrate on the apparatus, as previously described. Larvae 282 
were presented with 10 identical sinusoidal stimuli of 200 Hz (440 ms duration, 60-80 283 
second ISI). This trial was repeated 3 times for each set of animals (24 larvae per test 284 
condition, per trial). To compare the response of animals raised at 50 or 128 per Petri 285 
dish, an average large distance (ALD) measurement (distance travelled at >21.1 mm s-1) 286 
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was taken for each animal over the 10 stimuli, and the ALD for all animals across 3 trials 287 
for each condition were calculated. To assess the development of fish housed at the two 288 
different densities, larvae were raised as described (section 2.1) and imaged (for detail 289 
see section 2.6). 290 
 291 
2.4.8 Choice of an appropriate interval for stimulus presentation 292 
To determine possible habituation to acoustic stimulation, the response of larvae to 293 
varying ISIs was investigated. For each experimental trial, five separate ISIs (15, 30, 45, 294 
60 and 120 seconds) were tested in turn on the same twenty-four test animals. Based on 295 
previous studies, a minimum gap of 15 minutes was placed in between each interval 296 
tested to allow animals to recover from any habituation (Best et al., 2008). For each ISI 297 
tested, multiple sinusoidal stimuli of 200 Hz were presented to larvae. The habituation 298 
experiment was carried out 3 times using different clutches of larvae. A test was also 299 
performed with a 1 second ISI, to exemplify true habituation. 300 
 301 
2.4.9 Assessment of the larval startle response after ototoxin exposure 302 
Larvae were individually loaded into each well in a total of 2 mL E3 medium, and left 303 
overnight. Three microplates were prepared per assessment, which provided data from 304 
12 animals at each of the treatments. Before treatment, rheotaxis and seeker response 305 
testing was performed (section 2.4.11). Larvae were then immersed in compound (see 306 
section 2.2; Suppl. Table S1), and at the end of treatment, animals were rinsed 3 times 307 
in E3 and rheotaxis and seeker response scoring was repeated. Larvae were then 308 
transferred to frosted microplates and placed onto the startle platform to equilibrate. A 309 
baseline recording of 60 seconds was taken at the beginning of equilibration to monitor 310 
pre-stimulation movement. Next, 8 sinusoidal tone bursts (section 2.4.2) were presented 311 
with a randomised ISI of 60-80 seconds. During each stimulus, a 10 second video 312 
recording was taken to capture AERs. Each compound trial was carried out over 3 313 
plates. Treatments were allocated by column using an in-house random number 314 
generator to remove positional bias. For each plate, 3 control columns were assigned to 315 
ensure that a startle response could be identified against a baseline recording. A single 316 
pre-determined control column per plate was used for statistical analysis to make animal 317 
numbers equal for each treatment group. To ensure identical exposure conditions for all 318 
plates, treatments were staggered. Each compound was tested over 3 separate trials 319 
using different clutches of larvae, at a temperature of 28±0.5°C.  320 
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 321 
2.4.10 Baseline recording 322 
To examine possible sedation effects of test substances, we analysed activity profiles 323 
from baseline recordings. Video footage of 60 seconds duration was taken for each plate 324 
at the start of the equilibration time and the Viewpoint software was used to determine 325 
the average speed of each animal. For comparison with animals sedated with 326 
anaesthetic, larvae were immersed in 0.1 µg/mL or 0.0125 µg/mL MS222 for 30 minutes. 327 
For the full startle assay and anaesthetic testing, a total of 72 larvae per trial were 328 
examined. Each compound was tested over 3 trials using different clutches of larvae. 329 
 330 
2.4.11 Rheotaxis and seeker response (SR) testing 331 
To examine functional damage after neuromast disruption further, and/or drug-induced 332 
behavioural effects, the same animals as in section 2.4.9 were subjected to tests for 333 
rheotaxis and seeker approach responsiveness. For rheotaxis testing, 0.5 mL E3 was 334 
dispensed at high speed through a pipette to the side of individual wells in turn, resulting 335 
in a circular flow of fluid around the well. This was repeated, so that each larva was 336 
tested twice. Rheotaxis behaviour was scored as follows: 2 = immediate rheotaxis 337 
(orientation of the larva towards the direction of flow); 1 = rheotaxis observed on second 338 
attempt; 0 = no rheotaxis. For seeker response (SR) evaluation, a previously described 339 
method was used (Winter et al., 2008). Briefly, larvae were tested by gently approaching 340 
them from behind with a 20 µL pipette tip (the “seeker”). The response was scored as 341 
follows: 3 = uncompromised escape (immediate movement as soon as the tip touched 342 
the water surface, at a distance from the larva); 2 = reduced escape, which required the 343 
seeker to be moved towards the larva; 1 = escape following touch; and 0 = absence of 344 
an escape with touch (see diagram in Graphical Abstract). 345 
 346 
2.5 Data collection and analysis 347 
For the DASPEI assay, data were collected manually by scoring (section 2.3) and all raw 348 
data were analysed using Prism 5.0 (GraphPad Software Inc., USA). For the startle 349 
assay, data were collected as previously described (section 2.4.1). Raw data from the 350 
Viewpoint software were then processed using macros written in Microsoft Excel, and 351 
analysed using Prism 5.0.  352 
 353 
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In all cases, datasets were assessed for deviations from a normal distribution using the 354 
D’Agostino-Pearson normality test, and for equality of variances using Bartlett's statistic. 355 
If tests indicated that a dataset deviated from a Gaussian distribution or had unequal 356 
variances, non-parametric methods were applied (e.g. Kruskal-Wallis and Dunn’s tests). 357 
For all other datasets, parametric methods were appropriate (e.g. ANOVA).  358 
 359 
In all analyses, we adopted a threshold value of 0.05α as statistically significant. In all 360 
cases, error bars are plotted as SEM. 361 
 362 
2.6 Imaging 363 
Anaesthetised fish were mounted in 1% low melting point agarose (CAS No. 9012-36-6) 364 
and imaged using a BX51 compound microscope, Camedia (C-3030ZOOM) camera and 365 
Cell B software (Olympus, UK). Images were assembled using Adobe Photoshop 366 
software (Adobe Inc., USA).  367 
 368 
3. RESULTS 369 
3.1 Neuromast hair cell staining and scoring 370 
To assess the effect of compounds on hair cell integrity, we treated larvae (5 dpf) with 371 
known mammalian ototoxins or control compounds, and then stained treated fish with 372 
two vital dyes, DASPEI and FM1-43FX, that are preferentially taken up by hair cells. All 373 
positive (ototoxic) compounds tested (neomycin, streptomycin, gentamicin, cisplatin, 374 
aspirin, copper sulphate) resulted in reduced DASPEI staining and demonstrated a 375 
statistically significant concentration-dependent reduction in DASPEI score, indicative of 376 
hair cell damage or loss (Figs. 2 and 3). Staining of the nasal epithelium was not 377 
affected by exposure to the various ototoxins tested; this served as an internal control for 378 
the reliability of the DASPEI staining method. The observed reduction in DASPEI 379 
staining also correlated with a decrease in FM1-43FX labelling in all cases, except with 380 
aspirin treatment (Fig. 2Fiv). In the case of aspirin, FM1-43FX labelling was not strongly 381 
reduced, indicating that some mechanotransductive activity remained after treatment. 382 
Three of the four compounds selected as negative controls (amoxicillin, cefazolin, 383 
melphalan) had no significant effect on hair cell labelling with either dye (Figs. 2 and 3). 384 
However, gemcitabine gave an unexpected positive result in the initial DASPEI test 385 
(Suppl. Fig. S1).  386 
 387 
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[Figure 2 to go near here] 388 
[Figure 3 to go near here] 389 
 390 
3.2 Sound pressure level measurement and calibration 391 
Summary data from SPL calibrations are shown for each frequency in Suppl. Fig. S2. 392 
Overall, there was a correlation of measurement between both media at individual fixed 393 
frequencies. SPL meter readings were positively correlated with the readings taken in 394 
both air and water (as the SPL meter reading increased, so did the SPL calculated from 395 
the microphone recordings). As predicted, there was a difference in microphone SPL 396 
measurements in air versus water for each frequency tested, varying from 14 to 24 dB 397 
SPL. Interestingly, there was an increase in the SPL recorded with the microphone as 398 
the frequency setting decreased, when compared with the SPL meter. This was 399 
unexpected and is explained by the resonance of the apparatus, which could not be 400 
detected by the SPL meter in air but was detectable in water using the microphone. 401 
 402 
3.3 Determination of threshold response of larvae to stimuli over a range of frequencies 403 
For all frequencies, the minimum startle responsiveness chosen was 40% (>40% of fish 404 
responding to stimulus). A summary of the manual scoring data is shown in Suppl. Table 405 
S3. 500 Hz was the highest frequency that elicited a larval response that could be 406 
tested using the speaker. Above this frequency, no reproducible larval response could be 407 
elicited, as the greater current required to drive stimulation at higher frequencies evoked 408 
a double startle as the speaker audibly clicked off. In addition, fewer than 40% of larvae 409 
per plate responded to even the loudest stimulus before distortion of the waveform at 410 
frequencies of 800 Hz and above. 411 
 412 
3.4 Plate type 413 
As summarised in Figure 4A, we found a significant effect of plate type (24- versus 48-414 
well) on the startle response, with larvae in the 24-well plate displaying a stronger startle 415 
response overall (two-way ANOVA; F (1, 32) = 8.72, P = 0.0058). The frequency of the 416 
stimulus had no effect on response strength (two-way ANOVA; F (7, 32) = 0.72, P = 417 
0.6529). It is noteworthy that plate type did not have the same effect at all frequency 418 
values (two-way ANOVA; F (7, 32) = 0.66, P = 0.7028). Taken together, these data 419 
supported the use of 24-well plates in the assay to ensure the most reproducible 420 
reactions.  421 
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 422 
3.5 Wave type 423 
We sought to determine whether an alternative stimulus wave shape (square) could elicit 424 
an improved larval response compared with a sinusoid (Fig. 4B, 4C). We found that both 425 
sinusoidal and square waveforms produced equally strong AERs (Paired t-test; t = 426 
0.6267, 22 d.f., P = 0.5373), with no difference in the proportion of responding larvae 427 
(Paired t-test; t = 0.6146, 23 d.f., P = 0.5449). We therefore chose to use the more 428 
conventional sine wave in the final procedure. 429 
 430 
3.6 Density of raising 431 
We found that larvae raised at a density of 50 per Petri dish produced a significantly 432 
stronger startle movement than those raised at 128 per dish (Mann Whitney U test; Fig. 433 
4D; 2.09 ± 0.13 (50/dish) compared with 1.62 ± 0.16 mm s-1 (128/dish); Mann Whitney U 434 
Statistic = 1743, 1 d.f., P = 0.0033). Larvae raised at the lower density displayed 435 
increased responsiveness to the stimulus when compared with those reared at the 436 
higher density (Unpaired t-test; Fig. 4E; 0.85 ± 0.044 compared with 0.64 ± 0.039; t = 437 
3.707, 142 d.f., P = 0.0003). The developmental progression and health of the larvae, 438 
however, did not appear to be affected by the altered rearing conditions. Qualitative 439 
assessment revealed that larvae raised at both densities inflated their swimbladders, 440 
and developed normal-sized jaw, ear and eye structures and a functional digestive tract 441 
(Suppl. Fig. S3). 442 
 443 
3.7 Choice of an appropriate interval for stimulus presentation 444 
To determine whether there was any habituation at different inter stimulus intervals 445 
(ISIs), we measured the startle response of individual larvae over 10 stimuli, and used 446 
linear regression to analyse the data. Inducing a deliberate habituation using 1 second 447 
ISIs showed that control fish were capable of learned habituation (Fig. 4F; Linear 448 
regression: r 2 = 0.7882, F (1, 7) = 26.05, P = 0.0014). The responsiveness, but not 449 
strength, of the AER was significantly decreased with an ISI of 30 seconds over 10 450 
stimuli, which was indicative of habituation. Intervals of 45 seconds or longer did not 451 
cause significant habituation (either in strength or responsiveness of AER; P >0.05). An 452 
ISI of 60 seconds (with a random variation up to 80 seconds) was selected for further 453 
work, as this did not cause habituation (Fig. 4F; Linear Regression: r 2 = 0.1179, F (1, 7) 454 
= 0.9359, P = 0.3656). The initial stimulus induced a consistently stronger AER than 455 
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subsequent stimuli, as shown by the one sample t-test (Fig. 4F; t (8) = 13.68, P < 456 
0.0001; t (8) = 26.46, P < 0.0001 for 1 and 60 second ISIs respectively), and was 457 
therefore removed from the datasets before performing regression tests. The maximum 458 
number of stimuli chosen in the final startle protocol was 8. 459 
 460 
[Figure 4 to go near here] 461 
 462 
3.8 Assessment of the larval startle response after ototoxin exposure  463 
As summarised in Figure 4, larvae treated with neomycin, streptomycin, gentamicin and 464 
aspirin demonstrated a significantly reduced high-speed distance moved in response to 465 
auditory stimulus. A reduction in startle response was (with the exception of gentamicin) 466 
only detectable at the highest concentrations that damaged nearly all the hair cells, 467 
based on data from the DASPEI assay. There was no statistically significant decrease in 468 
AER at the IC50 level for any other compound, despite observing some reduction in high 469 
speed larval movement. Compounds for which DASPEI staining was unaffected 470 
(negative control compounds) had no significant effect on the response of animals to 471 
auditory stimulation.  472 
 473 
Interestingly, immersion in cisplatin and copper sulphate did not result in a significantly 474 
decreased AER, even at the concentrations required to elicit complete loss of DASPEI 475 
staining (Fig. 5D, E). As an independent assessment of hair cell integrity, we examined 476 
GFP expression in the transgenic Tg(pou4f3::mGFP) line. In transgenic larvae treated 477 
with copper sulphate, GFP expression was unaltered in pLL hair cells up to one hour 478 
post-treatment, even though live hair cell labelling with DASPEI and FM1-43FX was 479 
reduced. Conversely, neomycin treatment reduced GFP expression in the pLL (Fig. 6). 480 
The presence of GFP-positive hair cells in the pLL of copper-treated larvae could 481 
indicate that some hair cell function remains, accounting for the unaltered AER. This also 482 
suggests that GFP expression in the Tg(pou4f3::mGFP) line is a more reliable indicator 483 
of hair cell function than either DASPEI or FM1-43FX staining. 484 
 485 
[Figure 5 to go near here] 486 
 487 
At the top dose level of treatment with all ototoxins, the startle response was not 488 
completely abolished, suggesting some maintenance of auditory function (Fig. 5). After 489 
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acute treatment with ototoxins, the inner ear hair cells of the transgenic 490 
Tg(pou4f3::mGFP) line maintained a high level of GFP expression, even when the GFP-491 
positive cells of the pLL were absent (Fig. 6). This is likely to be because the ototoxins 492 
were unable to access the inner ear, and so inner ear hair cells were protected from 493 
damage. These data indicate a role for the inner ear in mediating the larval startle 494 
response. 495 
 496 
[Figure 6 to go near here] 497 
 498 
3.9 Baseline recording  499 
Analysis of baseline recordings revealed no significant effect on the average swimming 500 
speed of treated larvae when compared with control groups for all but one of the test 501 
substances (Table 1). Treatment with 100 µM neomycin resulted in a significant 502 
decrease in average speed compared with untreated larvae (2.119 ± 0.23 compared with 503 
3.467 ± 0.20 mm s-1 respectively; Kruskal-Wallis test, H = 15.83, 2 d.f., P = 0.0004), 504 
suggesting that neomycin had a sedative effect (Table 1). To assess this possibility, 505 
neomycin was retested in the final startle protocol alongside two concentrations of 506 
MS222 anaesthetic (0.1 µg/mL or 0.0125 µg/mL). The higher concentration of 507 
anaesthetic induced a state of full sedation and non-responsiveness after 2 minutes. The 508 
lower concentration was insufficient to cause full sedation after a 30 minute exposure 509 
and caused only a mild decline in responsiveness. The average speed of neomycin-510 
treated larvae was significantly faster than those treated with the higher concentration of 511 
MS222 (Suppl. Fig. S4A; 2.409 ± 0.27 versus 1.229 ± 0.21 mm s-1; Dunn’s test, P 512 
<0.05), but not different from the lower concentration (2.409 ± 0.27 versus 2.572 ± 0.19 513 
mm s-1; Dunn’s test, P >0.05). Thus, the effects of 100 µM neomycin treatment are 514 
comparable to slight, not heavy, sedation. 515 
 516 
[Table 1 to go near here] 517 
 518 
3.10 Rheotaxis and seeker response (SR) testing 519 
Significant disruption of rheotactic behaviour was observed after treatment with the 520 
aminoglycosides (neomycin, streptomycin, gentamicin), cisplatin and aspirin (Table 2). 521 
Surprisingly, copper sulphate treatment did not alter rheotactic behaviour significantly, 522 
even at a concentration sufficient to damage the majority of hair cells based on the 523 
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DASPEI assay.  Neither the solvent nor the negative controls showed any difference in 524 
rheotaxis scoring before or after treatment. 525 
 526 
In the seeker response (SR) test, all of the ototoxic compounds reduced the overall SR 527 
score by at least 46% at the top-concentration level, indicative of a decreased 528 
responsiveness to stimulation through the water (summarised in Table 2). Exposure to 529 
ototoxins did not affect the ability of larvae to respond to direct touch in the SR assay, 530 
suggesting that neuromuscular function remained intact. The negative controls, 531 
amoxicillin and cefazolin, had no significant effect on SR score. Interestingly, however, 532 
melphalan treatment caused a 14% reduction in responsiveness at the top concentration 533 
of 400 µM. In all cases, treatment with solvent/dilution water control had no significant 534 
effect on the SR score (Table 2). 535 
 536 
[Table 2 to go near here] 537 
 538 
To identify any subtle differences between MS222-induced light sedation and 100 µM 539 
neomycin treatment, the rheotaxis and SR scores were analysed (Suppl. Fig. S4). Both 540 
light sedation and neomycin treatment caused a reduction in rheotaxis score, but not a 541 
complete loss of the response (1.981 ± 0.019 to 1.583 ± 0.173 (P <0.01) and 2.000 ± 0.0 542 
to 1.194 ± 0.1 (P <0.0001) respectively; Bonferroni test). However, the effects of 543 
neomycin on this behaviour were more pronounced (a reduction of 40.3% compared 544 
with 20.2% for light sedation). In the SR test, scores were also significantly reduced for 545 
both light sedation and neomycin treatment (2.426 ± 0.067 to 2.028 ± 0.169 (P <0.05) 546 
and 2.463 ± 0.098 to 1.222 ± 0.073 (P <0.0001) respectively; Bonferroni test). Again, a 547 
greater decline in responsiveness to the seeker was seen with neomycin treatment (a 548 
reduction of 50.4% compared with 16.5% for light sedation). Thus, 100 µM neomycin 549 
treatment is sufficient to induce a decline in movement comparable with slight sedation, 550 
but displays stronger effects on rheotaxis and SR. This suggests that neomycin 551 
treatment (at the level required to damage the majority of hair cells in the DASPEI assay) 552 
is not simply inducing a sedative effect and that sedation alone does not account for the 553 
observed loss of AER. 554 
 555 
4. DISCUSSION 556 
4.1 Overview 557 
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We have described the development and optimisation of a semi-automated startle assay 558 
to assess the AER of larval zebrafish following exposure to a range of ototoxins, 559 
together with assays for rheotaxis and avoidance behaviour. We have demonstrated that 560 
ototoxin-induced cellular damage specific to the lateral line is sufficient to attenuate the 561 
auditory-evoked high speed escape response, rheotactic behaviour and sensitivity of 562 
motion detection in the larval zebrafish. We have determined that auditory-evoked startle 563 
alone cannot act as an indicator of sub-pathological effects of ototoxins (Froehlicher et 564 
al., 2009), but could be used in conjunction with additional histopathological (e.g. 565 
DASPEI) and functional assays (e.g. rheotaxis and SR tests), as a reliable indicator of 566 
the ototoxicity of new compounds.  567 
 568 
4.2 The DASPEI assay is a robust and sensitive indicator of ototoxicity  569 
A number of compounds is known to be toxic to human and mammalian hair cells 570 
(Guthrie, 2008; Rybak and Ramkumar, 2007; Rybak et al., 2007). To examine if 571 
zebrafish hair cells are similarly sensitive to a wide range of compounds, we exposed 572 
zebrafish larvae to a series of compounds with known ototoxic effect in mammals, or to 573 
negative controls with no known mammalian or human effect. To assay for hair cell 574 
damage, we used the styryl dye DASPEI, which is readily taken up by sensory hair cells 575 
present in the neuromasts of the lateral line and by cells of the nasal epithelium. A 576 
scoring system was used to quantify ototoxin-induced hair cell damage in neuromasts of 577 
the posterior lateral line, as the level of DASPEI staining has been shown to be 578 
proportional to the number of hair cells present in the neuromast, using methods such as 579 
phalloidin and acetylated tubulin labelling (Harris et al., 2003). The aminoglycoside 580 
antibiotics neomycin, streptomycin and gentamicin, the platinum-based 581 
chemotherapeutic cisplatin and the heavy metal salt copper sulphate were all sufficient 582 
to induce concentration-dependent loss of DASPEI staining and to reduce FM1-43FX 583 
staining in hair cells, indicating ototoxicity. This is in agreement with previously published 584 
data in zebrafish (Chiu et al., 2008; Coffin et al., 2010; Harris et al., 2003; Hernández et 585 
al., 2006; Ou et al., 2007; Ou et al., 2010; Owens et al., 2007; Owens et al., 2009; Ton 586 
and Parng, 2005; Van Trump et al., 2010). In addition, we tested the salicylate aspirin, a 587 
reported ototoxin in humans, and found that similar concentration-dependent hair cell 588 
damage occurred with DASPEI but not FM1-43FX labelling. 589 
 590 
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A small subset of negative control compounds with similar therapeutic effect in humans 591 
to the ototoxins, but no documented ototoxic side effects, were examined. These 592 
included two antibiotics (the synthetic penicillin amoxicillin and the first generation 593 
cephalosporin cefazolin), and two chemotherapeutics (the alkylating agent melphalan 594 
and the anti-metabolite gemcitabine). The latter were selected as agents expected to 595 
affect cell survival and differentiation, by disrupting DNA synthesis and cell division 596 
(Brunton et al., 2006). Cefazolin and amoxicillin have not previously been investigated 597 
for their ototoxic effects in the zebrafish. The chemotherapeutics melphalan and 598 
gemcitabine have been shown to have no hair cell toxicity in a recent screen (Hirose et 599 
al., 2011). Amoxicillin, cefazolin and melphalan had no significant effect on hair cell 600 
staining, and therefore no ototoxic effect. In contrast to the findings of the published 601 
screen (Hirose et al., 2011), gemcitabine exposure resulted in a significant reduction in 602 
hair cell labelling, thus scoring as positive in our assay. A plausible reason for this 603 
discrepancy is that DASPEI labels mitochondria, whereas Hirose and colleagues used 604 
the nuclear dye YOPRO-1, which could be less sensitive to subtle cellular alterations 605 
following treatment. One explanation for the lack of reported ototoxicity of gemcitabine in 606 
humans is that patients treated with gemcitabine are typically treated with gemcitabine-607 
cisplatin adjuvant therapy (Joint Formulary Committee, 2011; Lee et al., 2004). It is 608 
therefore possible that the known ototoxin, cisplatin, may mask any additional ototoxic 609 
effect of the gemcitabine in patients. Additionally, the concentration of gemcitabine used 610 
in our experiments is likely to be higher than the effective concentration used in humans, 611 
due to the direct exposure of the neuromasts to the compound. The human ear is less 612 
likely to encounter such high levels. 613 
 614 
4.3 Control compliance of larvae in the startle assay is dependent on many factors, 615 
including raising density and inter stimulus interval 616 
 617 
The startle response (Bang et al., 2002; Kimmel et al., 1974; Zeddies and Fay, 2005) 618 
formed the basis of a functional assay to measure physiological endpoints following 619 
ototoxic insult and subsequent hair cell damage. One major obstacle in examining startle 620 
responses is that the high speed AER of the larvae (at least in the case of SLCs) is 621 
probabilistic (Burgess and Granato, 2007). In our investigation, the startle response 622 
initially occurred in only approximately 40% of untreated larvae. A number of parameters 623 
were refined in order to increase the percentage of control animals responding to stimuli, 624 
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thereby optimising the assay. In particular, raising density, ISI duration and plate type 625 
were found to be key determinants of control compliance. 626 
 627 
It has previously been reported that larval raising conditions can have a direct effect on 628 
sensitivity to auditory stimuli, with larvae raised at lower densities showing significantly 629 
greater responsiveness (Burgess and Granato, 2008). In agreement with Burgess and 630 
Granato, our data show that AER is significantly increased in the lower raising density 631 
condition. This effect is unlikely to be explained by a developmental delay, as larval 632 
development appeared to be unaffected in the large sample of animals tested. More 633 
likely, it is not unreasonable to assume that larvae raised at a higher density will come 634 
into physical contact with other larvae more frequently, and experience a higher 635 
background level of underwater motion. This added stimulation at higher raising 636 
densities may desensitise the larval zebrafish to subsequent artificial vibratory 637 
stimulation (Domenici, 2010). 638 
 639 
It is well documented that repeated exposure to a given stimulus results in a progressive 640 
reduction in response (Rankin et al., 2009; Thompson and Spencer, 1966). This 641 
phenomenon, termed habituation, is present in the larval zebrafish, occurring as a 642 
consequence of repeated exposure to tone bursts. To determine the appropriate 643 
duration between stimuli for this investigation, the response to varying ISIs was 644 
investigated. In agreement with previous work (Best et al., 2008), our data confirmed 645 
that movement elicited by the first auditory stimulus is significantly greater than that 646 
brought about by successive stimuli. This justifies the removal of the first stimulus from 647 
further testing, as this immediate difference is not a habituation effect. In addition, we 648 
were able to induce habituation deliberately using an ISI of 1 second, thus further 649 
supporting that larvae are indeed capable of this behaviour. In our investigation, 650 
habituation did not occur over repeated stimuli with an ISI of 45 seconds or more. 651 
Previous studies have used an ISI of 15-20 seconds, which was shown to be insufficient 652 
to induce habituation (Best et al., 2008; Burgess et al., 2009). One study (Zeddies and 653 
Fay, 2005) used a much longer ISI of 105 ± 30 seconds, and in agreement with this, we 654 
found that an ISI longer than 45 seconds prevented habituation. We propose that the 655 
minor discrepancies in larval habituation are due to inter-strain variation and different 656 
experimental methodology between studies. Based on these results, an ISI of 60 657 
seconds with a random variation of up to 20 seconds was selected in order to prevent 658 
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habituation, and to streamline the experimental protocol to allow immediate video 659 
processing. 660 
 661 
In early pre-clinical screens, it is important to maximise the quality and throughput of 662 
assays by optimising for sample size (i.e. n number). To test whether the capacity of our 663 
assay could be increased by using more wells per experiment, without affecting the 664 
acoustic properties or startle response of the animals, larval AERs were compared 665 
between 24- and 48-well plates. These data indicated that the best response could be 666 
observed using 24-well plates. Ultimately, this result limited the throughput of the assay 667 
and introduced a necessity for staggered treatments to maintain an appropriate number 668 
of animals per treatment group, but provided what appeared to be more robust data with 669 
lower variability.  670 
 671 
4.4 The startle assay provides a readout of the functional consequences of ototoxic 672 
damage 673 
 674 
Following optimisation of the startle assay, it was possible to assess the effects of the 675 
positive and negative compounds on the AER. It was hypothesised that test substances 676 
that caused a significant reduction in DASPEI fluorescence would also induce a 677 
functional effect, in the form of a reduced response to sinusoidal tone bursts over a 678 
range of frequencies. Results from the assay confirmed that certain ototoxins, including 679 
all of the aminoglycoside antibiotics and aspirin, caused a decrease in AER at the 680 
highest concentrations tested. These observations concur with data showing that lateral 681 
line toxins attenuate the C-start in zebrafish and other fish species, and with 682 
electrophysiological studies demonstrating that auditory evoked potentials can be 683 
recorded from the brainstem and are reduced after gentamicin exposure in goldfish 684 
(Brack and Ramcharitar, 2011; Faucher et al., 2006; Faucher et al., 2008; McHenry et 685 
al., 2009; Ramcharitar and Selckmann, 2010; Ramcharitar and Brack, 2010; Weber, 686 
2006). The neurotoxin lead is also reported to cause alterations in larval zebrafish startle 687 
responses, although it is uncertain how closely this damage is linked to hair cell toxicity 688 
(Rice et al., 2011). 689 
 690 
4.5 The startle assay is less sensitive than the DASPEI assay in detecting ototoxicity 691 
 692 
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Positive compounds that induced cellular damage, namely cisplatin and copper 693 
sulphate, were not shown to have any significant effect on response in the startle assay. 694 
The fact that the startle assay could not detect AER decreases for these compounds is 695 
best explained by the high variability of response between test animals and not by drug-696 
induced activity changes leading to desensitisation to stimulation (as there was no 697 
change in baseline activity of larvae). As the hair cells of the lateral line were damaged 698 
after treatment with both compounds, the undamaged hair cells of the inner ear may 699 
have allowed for an uncompromised response. Additionally, some lateral line hair cell 700 
function may have remained even in the absence of DASPEI and FM1-43FX staining, 701 
thus explaining the differences in AER effects between aminoglycosides, cisplatin and 702 
copper sulphate. However, the startle assay is advantageous in that it does not suffer 703 
from one of the main drawbacks of the use of larval zebrafish for early toxicology 704 
screens, whereby uptake of compound is chemistry-dependent. Poor uptake of 705 
compounds in other assays can result in low potency for some compounds when based 706 
on applied concentration (Redfern et al., 2008; Richards et al., 2008; Winter et al., 707 
2008). In all of our assays, cells are directly exposed to the applied concentration of 708 
compound in the aqueous medium, avoiding this problem.  709 
 710 
The positive control, neomycin, gave consistent results, with a decrease in AER 711 
observed in 89% of cases. Overall, the startle assay was only sensitive at high 712 
concentrations that were sufficient to bring about complete hair cell damage (based on 713 
DASPEI staining). The reason for this low comparative sensitivity could at least in part 714 
be due to the stringent method of defining the startle movement. In this assay, 715 
movements below a high-speed threshold were not recorded as startle responses. 716 
These movements tended to include a weak C-bend but not the full range of motion 717 
expected from a stereotypical startle. The inclusion of these less marked responses in 718 
future may be sufficient to increase the initial control compliance levels, and therefore 719 
any compound-induced decreases in AER would prove more significant.  720 
 721 
4.6 The ear may contribute to larval startle responses 722 
 723 
Acute exposure of larvae to ototoxins is thought to cause damage specific to the lateral 724 
line that does not affect the ear (Blaxter and Fuiman, 1989; Matsuura et al., 1971). This 725 
is likely to be because ototoxins applied to the medium in which the larvae are swimming 726 
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are unable to access the ear: inner ear hair cells are susceptible to ototoxic damage if 727 
compounds are injected directly into the otic lumen (L. Buck, data not shown). In our 728 
assays, although startle responses were significantly attenuated for the aminoglycosides 729 
and aspirin at concentrations that abolished pLL DASPEI staining completely, the 730 
reaction was not entirely diminished. Additionally, we found that acute treatment with 731 
ototoxins did not affect the levels of GFP expression or the morphology of inner ear hair 732 
cells. These findings are of real value as they imply that the ear contributes to initiating 733 
the noise-evoked startle. This would support the previous implication that the sacculus 734 
partly mediates the startle response (Zeddies and Fay, 2005). Further investigation will 735 
be necessary to separate out the roles of the ear versus the lateral line for this 736 
behaviour. 737 
 738 
4.7 Rheotaxis and seeker response assays offer sensitive readouts of ototoxin-induced 739 
functional damage 740 
 741 
Rheotactic behaviour in response to artificial circular currents was examined in larvae 742 
treated with ototoxins. The mechanosensory lateral line is a key mediator of rheotactic 743 
behaviour in zebrafish (Johnson et al., 2007) and other fish species (Montgomery et al., 744 
1997). We hypothesised that lateral line-specific hair cell damage induced by ototoxins 745 
would lead to a decrease in rheotaxis score but that this decline in behaviour would not 746 
be observed in solvent- and negative control-treated larvae. Our data supported this 747 
hypothesis in the main. This is in line with data from other fish species, such as whitebait 748 
and blind cave fish, in which ototoxins and heavy metals are sufficient to raise the 749 
threshold for rheotactic responses (Baker and Montgomery, 2001; Montgomery et al., 750 
1997). It was surprising that copper sulphate did not affect rheotaxis in our experiments, 751 
as this effect has previously been observed in larval zebrafish in response to copper 752 
exposure (Johnson et al., 2007). The effects of copper may have gone undetected in our 753 
investigation due to the presence of pLL hair cells (based on GFP expression in the 754 
Tg(pou4f3::mGFP) line) even in the absence of live cell labelling with DASPEI. These 755 
results cannot be explained by alterations in baseline activity of larvae (e.g. seizure 756 
induction). Nevertheless, testing for rheotactic disturbance proved more sensitive than 757 
the startle assay by direct comparison (Suppl. Table S4).  758 
 759 
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The seeker response (SR) test served to answer two questions; are larvae responsive to 760 
water flow disturbances, and do they retain neuromuscular function after compound 761 
exposure? It was predicted from previous data based on neomycin alone that ototoxin 762 
treatment would cause a decreased responsiveness to water flow (McHenry et al., 763 
2009). It was also hypothesised that negative compounds would have no discernable 764 
effect. This was true for all compounds, except melphalan, which gave an unexpected 765 
minor decrease in SR score. As melphalan treatment did not alter the activity profile of 766 
the larvae, the result could not be attributed to a sedative effect. Reduction in SR score 767 
is a third functional consequence of lateral line hair cell damage. 768 
 769 
4.8 Sedation and seizure induction do not account for alterations in functional responses 770 
to exogenous stimuli 771 
 772 
To exclude the possibility that the reduction in startle response after exposure to 773 
ototoxins was due to sedative effects, we analysed the activity profiles of the larvae from 774 
baseline recordings. With the exception of neomycin, all test substances had no 775 
significant effect on the overall movement of larvae. When compared with the 776 
anaesthetic MS222, it appeared that the decreased activity caused by neomycin 777 
exposure might have been due to slight sedative effects. Interestingly, the decrease in 778 
baseline activity of neomycin-treated larvae could not solely be attributed to sedative 779 
effects, as neomycin treatment displayed more pronounced effects on rheotaxis and 780 
seeker response than light sedation. These findings lead us to believe that a more 781 
subtle, compound-specific effect is occurring with neomycin treatment. 782 
 783 
4.9 CONCLUDING REMARKS 784 
These data are the first to demonstrate that larval zebrafish can experience deficits in 785 
detecting auditory and vibratory stimuli, and in orientation to current flow, after cellular 786 
damage induced by a range of ototoxins. Our findings collectively recapitulate the 787 
functional hearing and vestibular effects manifested in humans and non-human 788 
mammals after exposure to these ototoxins, thereby further supporting the use of 789 
zebrafish as a pre-clinical indicator of drug-induced ototoxicity.  790 
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FIGURE AND TABLE LEGENDS 1045 
Figure 1. Experimental setup used to evoke startle responses in larval zebrafish. 1046 
(A) Stimuli were generated with a PC function generator, amplified, and directed through 1047 
a speaker cone. Acoustic stimuli were delivered to the larvae through a plastic base 1048 
plate, bolted to the speaker case. AERs were captured using a high speed digital video 1049 
camera. Recordings were visualised and processed using VideoTrack software. The 1050 
threshold used to distinguish between normal and stereotypical startle-type locomotor 1051 
activity (shown in red) was 21.1 mm s-1. (B) Treatment and testing paradigm used in the 1052 
startle, SR and rheotaxis assays.  1053 
 1054 
Figure 2. The effects of compounds on DASPEI and FM1-43FX staining in the pLL. 1055 
Ototoxin treatment reduced DASPEI and FM1-43FX staining in the hair cells of the pLL 1056 
compared to control larvae. Other staining, including the nasal epithelium and ear, was 1057 
not affected in treated larvae (Rows A-F). Treatment with negative control compounds 1058 
did not reduce the brightness of DASPEI or FM1-43FX labelling in the pLL compared to 1059 
control larvae (Rows G-I). The images shown are representative of all fish tested (12 1060 
larvae per treatment group). Scale bar = 800 µm. (Ji) Schematic showing typical pattern 1061 
of neuromasts in a 5 dpf zebrafish larva. Smaller neuromasts from the second wave of 1062 
deposition are indicated (II-1, II-2), but were not scored for the purpose of the DASPEI 1063 
assay. The remaining 9 neuromasts of the pLL (P1-9) were scored on both sides. (Jii-iii) 1064 
Exemplar images of neuromast staining with DASPEI. Image (Jii) is representative of a 1065 
healthy neuromast given a score of 2 in the fluorescence assay. Image (Jiii) is 1066 
representative of a damaged neuromast, given a score of 1. Scale bar = 20 µm. 1067 
 1068 
Figure 3. Concentration-response relationships of known ototoxins and negative 1069 
control substances in larval zebrafish. (A-F) Exposure to the ototoxins neomycin, 1070 
streptomycin, gentamicin, cisplatin, aspirin and copper sulphate caused a significant 1071 
concentration-dependent decrease in DASPEI staining, indicative of hair cell damage 1072 
(Kruskal-Wallis test, followed by Dunn’s multiple comparison test). Exposure time and 1073 
concentration range were as described in Suppl. Table S1. (G-I) Exposure to the 1074 
negative controls amoxicillin (G), cefazolin (H) and melphalan (I) had no significant effect 1075 
on DASPEI staining (Kruskal-Wallis test, followed by Dunn’s multiple comparison test). 1076 
Minimum of 29 fish per group (pooled from 3 or more experimental trials). Statistical 1077 
significance compared with the control group is indicated by asterisks. * P < 0.05, ** P < 1078 
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0.01, *** P < 0.001, ns P > 0.05 (applies to all subsequent figures and tables). The first 1079 
observed statistical effect is denoted by the hash symbol (#). (J) IC50 values were 1080 
approximated using either log(concentration of test compound) versus response (three 1081 
parameters) or log(concentration of test compound) versus response - Variable slope 1082 
(four parameters) curve-fitting equations. 1083 
 1084 
Figure 4. Factors contributing to the control compliance of larval AERs. (A) Overall, 1085 
untreated larvae displayed stronger AERs when arrayed into microplates containing 24 1086 
wells compared with 48 wells (two-way ANOVA; F (1, 32) = 8.72, P = 0.0058). (B, C) 1087 
Paired t-tests indicated that both sine and square waveforms elicited equally strong 1088 
startle responses (based on the strength of response and the percentage of animals 1089 
responding). (D, E) A density of 50 larvae per Petri dish gave both the strongest startle 1090 
response (Mann Whitney test) and the highest percentage of untreated larvae startling 1091 
(unpaired t-test), when compared with a higher density of 128 larvae per Petri dish.  (F) 1092 
The habituation profile of larvae over 10 repeated stimuli, with an ISI of 1 second or 60 1093 
seconds. For graphs (C) and (E), statistical testing was performed on values that had 1094 
been normalised using Arcsine transformation. See Methods, sections 2.4.5 to 2.4.8, for 1095 
n numbers. 1096 
 1097 
Figure 5. Specific ototoxins caused a concentration-dependent decrease in larval 1098 
AER following histological damage. The positive control was neomycin 100µM. 1099 
Minimum of 36 larvae pooled from 3 experimental repeats per condition. All data were 1100 
analysed using the Kruskal-Wallis test, followed by Dunn’s multiple comparison test. 1101 
Statistical significance compared with the control group is indicated by asterisks. For 1102 
details of compound exposures see Suppl. Table S1. 1103 
 1104 
Figure 6. The effects of copper sulphate and neomycin exposure on the ear and 1105 
pLL of Tg(pou4f3::mGFP) larvae. Treatment with neomycin and copper sulphate (E-H) 1106 
did not affect GFP expression in the hair cells of the inner ear when compared to control 1107 
treatment (A-D). These images were taken at both the anterior and posterior focal planes 1108 
in live animals. A, anterior macula; P, posterior macula; arrowheads indicate the cristae 1109 
of the semicircular canals. Scale bar = 200 µm. Treatment with neomycin (K) but not 1110 
copper sulphate (L) caused a strong decrease in GFP expression in hair cells of the pLL, 1111 
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when compared to control treatment (I and J). Scale bar = 500 µm. Images are 1112 
representative of an n of 12 per treatment group. 1113 
 1114 
Table 1. Movement profiles of drug-treated larvae helped to identify potentially 1115 
sedative effects of compounds. Neomycin treatment reduced the average speed of 1116 
unstimulated larvae (Kruskal-Wallis test; H = 15.83, 2 d.f., P = 0.0004). All other 1117 
histologically positive and negative compounds had no significant reduction in average 1118 
speed of the larvae over a 60 second recording. Minimum of 36 larvae pooled from 3 1119 
experimental repeats per condition. Statistical tests performed were one-way ANOVA 1120 
(followed by Dunnett's multiple comparison tests) or Kruskal-Wallis test (followed by 1121 
Dunn’s multiple comparison test). For details of compound exposures see Suppl. Table 1122 
S1. 1123 
 1124 
Table 2. Rheotaxis and seeker response scores decreased in a concentration 1125 
dependent manner with ototoxin exposure. Data are presented as the percent 1126 
reduction in score following treatment with either the water/solvent control, test 1127 
compound or positive control for all test substances. Statistical data from post-tests are 1128 
displayed in the adjacent column (for all post-test data, d.f. = 1). All data were analysed 1129 
using two-way ANOVA, followed by Bonferroni multiple comparison tests. Minimum of 36 1130 
larvae pooled from 3 experimental repeats per condition. For details of compound 1131 
exposure, see Suppl. Table S1. 1132 
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SUPPLEMENTARY FIGURE AND TABLE LEGENDS 1 
 2 
Supplementary Figure S1. Concentration-response data for gemcitabine 3 
hydrochloride. (A) Exposure to gemcitabine hydrochloride caused a significant 4 
concentration-dependent decrease in DASPEI staining, indicative of hair cell damage 5 
(One-way ANOVA followed by Dunnett’s tests; F (4, 21) = 197.3, P <0.0001). Exposure 6 
time and concentration range as described in Suppl. Table S1. 5 larvae per treatment 7 
group were assessed over a single trial. (B) The estimated IC50 value for gemcitabine 8 
(log(concentration of test compound) vs. response (three parameters) curve-fitting 9 
equation). 10 
 11 
Supplementary Figure S2. The relationship between sound pressure level 12 
measurements and microphone SPL in air versus water.  13 
 14 
Supplementary Figure S3. Development was unaffected by altering the density at 15 
which larvae are raised. (A-D) Representative images of larvae reared at a density of 16 
50 per Petri dish (taken from a sample of 150 animals). (E-H) Representative images of 17 
larvae reared at a density of 128 per Petri dish (taken from a sample of 128 animals). 18 
Note normal development of eye, body pigmentation, body length, and swimbladder 19 
inflation for all animals. Scale bar = 500 µm. 20 
 21 
Supplementary Figure S4. The effects of neomycin versus MS222 on the 22 
movement profile, rheotaxis and SR score of larvae. (A-B) Examination of the 23 
baseline movement profiles of larvae treated with top concentration neomycin or 24 
anaesthetic (analysed using Kruskal-Wallis test and Dunn’s post-tests). (C-D) Rheotaxis 25 
and SR scores alter after immersion in neomycin or anaesthetic. Data from three 26 
experimental trials were analysed using Two-way ANOVA, followed by Bonferroni 27 
multiple comparison tests. Statistical significance level (α) is denoted by asterisks (*). 28 
For n numbers see section 2.4.10. 29 
 30 
Supplementary Table S1 Compound exposure details. Treatments were performed 31 
as shown for each assay. MTC was defined as the concentration of compound to elicit 32 
more than 20% mortality within a single treatment group. For n numbers see section 2.2. 33 
 34 
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 2 
Supplementary Table S2 Individual stimulus settings. The stimulus duration and 35 
factors controlling the signal amplitude are shown for each individual frequency tested.  36 
 37 
Supp Table S3 Threshold testing in control larvae. Amplifier volume settings that 38 
elicited an average response of more than 40% of fish over three experimental trials are 39 
shown. Fewer than 40% of fish responded at 800Hz, even at the top volume before 40 
waveform distortion. For n numbers see section 2.4.4. 41 
 42 
Supplementary Table S4 The comparative sensitivities of the histological and 43 
functional assays. The various sensitivities are presented for each method. The most 44 
sensitive assay is decided first by lowest detectable concentration effect and then by 45 
significance level (α) at that concentration.   46 








